HealthQuill Gene Mutation
AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the Anglo-Swedish company.
Drugs Health Pharma

AstraZeneca says trial breast cancer drug improves survival rates

AstraZeneca Plc.’s end-stage trials of its investigational drug for advanced breast cancer have increased survival rates in patients, results show, according to the.

Read More
Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to a National Institute for Health and Care Excellence (NICE) statement.
Drugs Health Medical

UK’s NHS to provide gene therapy that may cure sickle cell  disease in adults

Britain’s National Health Service will provide a gene therapy that may cure sickle cell disease for patients 12 years and older, according to.

Read More
Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six years and older, according to a statement from the company.
Drugs Health Medical Research

Vertex gets US regulator’s nod for extended use of cystic fibrosis drug

Vertex Pharmaceuticals Inc.’s Alyftrek drug got clearance from the Food and Drug Administration to expand its treatment for cystic fibrosis in people six.

Read More
The USFDA has cleared AstraZeneca’s lung cancer drug Tagrisso with chemotherapy for treatment in adult patients.
Drugs Health Pharma

AstraZeneca’s non-small lung cancer therapy gets FDA clearance

HQ Team February 17, 2024: The USFDA has cleared AstraZeneca’s Tagrisso with chemotherapy for treatment in adult patients with non-small cell lung cancer..

Read More